Agilis Biotherapeutics
Agilis is a biotechnology company that engages in developing gene-based therapeutics for rare monogenic diseases that affect the central nervous system.
Business Model:
Revenue: $3M
Employees: 51-200
Rankings
Detailed Agilis Biotherapeutics Information
Agilis Biotherapeutics was acquired by
PTC Therapeutics.
The acquisition happend on 2018-07-19.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 6 Kimball Lane
City: Lynnfield
State: MA
Zip: 01940
Country: US
Financial Info
Stage:
series unknown
Raised Last:
$13M
Raised Total:$21M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Agilis is a biotechnology company that engages in developing gene-based therapeutics for rare monogenic diseases that affect the central nervous system.
Contact Phone:
+13394405818
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 2/2017 | Venture Round | 1 | $12.7M |
Sands Capital Ventures Sands Capital Ventures |
1/2014 | Series A | $8M | 12/2013 | Equity | $8M | 2/2017 | Equity | $12.7M |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
